Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. L 364,718
2. L-364,718
3. L364,718
4. Mk 329
5. Mk-329
6. Mk329
1. 103420-77-5
2. Mk-329
3. Devazepidum
4. Mk 329
5. Devazepida
6. L-364,718
7. (s)-n-(2,3-dihydro-1-methyl-2-oxo-5-phenyl-1h-1,4-benzodiazepin-3-yl)indole-2-carboxamide
8. L 364718
9. Je6p7qy7nh
10. L-364718
11. Chembl9506
12. Chebi:4460
13. 3(s)-(-)-1,3-dihydro-3-(2-indolecarbonylamino)-1-methyl-5-phenyl-2h-(1,4)benzodiazepin-2-one
14. Ncgc00159551-01
15. Dsstox_cid_26092
16. Dsstox_rid_81331
17. Dsstox_gsid_46092
18. 1h-indole-2-carboxamide, N-(2,3-dihydro-1-methyl-2-oxo-5-phenyl-1h-1,4-benzodiazepin-3-yl)-, (s)-
19. Brn 5156082
20. (s)-n-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1h-benzo[e][1,4]diazepin-3-yl)-1h-indole-2-carboxamide
21. N-[(3s)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1h-1,4-benzodiazepin-3-yl]-1h-indole-2-carboxamide
22. Cas-103420-77-5
23. Devazepide [usan:inn]
24. Devazepidum [inn-latin]
25. Unii-je6p7qy7nh
26. Devazepida [inn-spanish]
27. Devacade
28. L 364,718
29. Devazepide [inn]
30. Devazepide (usan/inn)
31. Devazepide [usan]
32. Cck Antagonist Synthetic 17
33. Cck Antagonist Synthetic 18
34. Schembl148766
35. Dtxsid2046092
36. Hms3268j20
37. 1h-indole-2-carboxylic Acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1h-benzo[e][1,4]diazepin-3-yl)-amide
38. Zinc1847292
39. Tox21_111744
40. Bdbm50005463
41. Nsc778303
42. Pdsp1_000936
43. Pdsp2_000922
44. Akos024457038
45. Devazepide, >=98% (hplc), Powder
46. Tox21_111744_1
47. Nsc-778303
48. N-[(3s)-1-methyl-2-oxo-5-phenyl-3h-1,4-benzodiazepin-3-yl]-1h-indole-2-carboxamide
49. Ncgc00159551-02
50. Hy-106301
51. B7008
52. Cs-0025544
53. D02693
54. J-000963
55. Q5266620
56. Brd-k31238592-001-01-6
57. (r)-1h-indole-2-carboxylic Acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1h-benzo[e][1,4]diazepin-3-yl)-amide: 0.1c4h10o
58. (s)-1h-indole-2-carboxylic Acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1h-benzo[e][1,4]diazepin-3-yl)-amide
59. (s,z)-n-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1h-benzo[e][1,4]diazepin-3-yl)-1h-indole-2-carboxamide
60. (z)-n-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1h-benzo[e][1,4]diazepin-3-yl)-1h-indole-2-carboxamide
61. 1h-indole-2-carboxylic Acid ((s)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1h-benzo[e][1,4]diazepin-3-yl)-amide
62. 1h-indole-2-carboxylic Acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1h-benzo[e][1,4]diazepin-3-yl)-amide (l-364,718 ((s)-devazepide)
63. 1h-indole-2-carboxylic Acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1h-benzo[e][1,4]diazepin-3-yl)-amide (mk-329, L-364,718)
64. 1h-indole-2-carboxylic Acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1h-benzo[e][1,4]diazepin-3-yl)-amide(devazepide Or (r) L364718)
65. 1h-indole-2-carboxylic Acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1h-benzo[e][1,4]diazepin-3-yl)-amide(devazepide)
66. 1h-indole-2-carboxylic Acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1h-benzo[e][1,4]diazepin-3-yl)-amide(l-364718)
67. 1h-indole-2-carboxylic Acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1h-benzo[e][1,4]diazepin-3-yl)-amide: 0.1c4h10o. 0.15ch2cl2
68. N-[(3s)-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1h-1,4-benzodiazepin-3-yl]-1h-indole-2-carboxamide
Molecular Weight | 408.5 g/mol |
---|---|
Molecular Formula | C25H20N4O2 |
XLogP3 | 4.2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 3 |
Exact Mass | 408.15862589 g/mol |
Monoisotopic Mass | 408.15862589 g/mol |
Topological Polar Surface Area | 77.6 Ų |
Heavy Atom Count | 31 |
Formal Charge | 0 |
Complexity | 716 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Hormone Antagonists
Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites. (See all compounds classified as Hormone Antagonists.)
ABOUT THIS PAGE
11
PharmaCompass offers a list of Devazepide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Devazepide manufacturer or Devazepide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Devazepide manufacturer or Devazepide supplier.
PharmaCompass also assists you with knowing the Devazepide API Price utilized in the formulation of products. Devazepide API Price is not always fixed or binding as the Devazepide Price is obtained through a variety of data sources. The Devazepide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Devazepide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Devazepide, including repackagers and relabelers. The FDA regulates Devazepide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Devazepide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Devazepide supplier is an individual or a company that provides Devazepide active pharmaceutical ingredient (API) or Devazepide finished formulations upon request. The Devazepide suppliers may include Devazepide API manufacturers, exporters, distributors and traders.
Devazepide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Devazepide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Devazepide GMP manufacturer or Devazepide GMP API supplier for your needs.
A Devazepide CoA (Certificate of Analysis) is a formal document that attests to Devazepide's compliance with Devazepide specifications and serves as a tool for batch-level quality control.
Devazepide CoA mostly includes findings from lab analyses of a specific batch. For each Devazepide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Devazepide may be tested according to a variety of international standards, such as European Pharmacopoeia (Devazepide EP), Devazepide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Devazepide USP).